Advanced search
Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 29, 2010 - Issue 2
Submit an article Journal homepage
302
Views
37
CrossRef citations to date
0
Altmetric
Original Article

The Use of Imiquimod in the Treatment of Periocular Tumours

A. H. RossBristol Eye Hospital, Lower Maudlin Street, Bristol, UKCorrespondence[email protected]
,
C. T. C. KennedyDepartment of Dermatology, University Hospitals Bristol Foundation Trust, Bristol, UK
,
C. CollinsDepartment of Pathology, University Hospitals Bristol Foundation Trust, Bristol, UK
&
R. A. HarradBristol Eye Hospital, Lower Maudlin Street, Bristol, UK
Pages 83-87 | Received 20 Jul 2009, Accepted 23 Aug 2009, Published online: 16 Apr 2010

REFERENCES

  • Berman B, Sullivan T, De Araujo T, Nadji M. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol. 2003 Nov;149 Suppl 66:59–61.
  • Blasi MA, Giammaria D, Balestrazzi E. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. Am J Ophthalmol. 2005 Dec;140(6):1136–1139.
  • Brannan PA, Anderson HK, Kersten RC, Kulwin DR.Bowen disease of the eyelid successfully treated with imiquimod. Ophthal Plast Reconstr Surg. 2005 Jul;21(4):321–322.
  • Cataltepe S, Gornstein ER, Schick C, Kamachi Y, Chatson K, Fries J, Silverman GA, Upton MP. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem. 2000 Jan;48(1):113–122.
  • Choontanom R, Thanos S, Busse H, Stupp T. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol. 2007 Aug; 245(8):1217–1220.
  • Flórez Á,Feal C, de la Torre C, Cruces M. Invasive squamous cell carcinoma treated with imiquimod 5% cream. Acta Derm Venereol. 2004;84:227–228.
  • Hengge UR, Benninghoff B, Ruzicka T, Goos M. Topical immunomodulators—progress towards treating inflammation, infection, and cancer. Lancet Infect Dis. 2001 Oct;1(3):189–198.
  • Hengge UR, Ruzicka T. Topical immunomodulation in dermatology: potential of toll-like receptor agonists. Dermatol Surg. 2004 Aug;30(8):1101–1112. Review.
  • Hengge UR, Schaller J. Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol. 2004 Apr; 140:404–406.
  • Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, Lee JH, Fox TL. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004 May; 50(5):714–721.
  • Leppälä J, Kaarniranta K, Uusitalo H, Kontkanen M. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Opthalmol Scand. 2007 Aug; 85(5):566–568. Epub 2007 Mar 22.
  • Martin-Garcia RF. Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma. Dermatol Surg. 2005 Mar;31(3):371–374.
  • Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis. 2001;1:3. Epub 2001 Jun 5. Review.
  • Nouri K, O’Connell C, Rivas MP. Imiquimod for the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Drugs Dermatol. 2003 Dec;2(6):669–673.
  • Oster-Schmidt C. Two cases of squamous cell carcinoma treated with topical imiquimod 5%. J Eur Acad Dermatol Venereol. 2004 Jan;18(1):93–95.
  • Oster-Schmidt C, Dirschka T. Therapy of cutaneous cell carcinoma in two retirement home residents. J Dtsch Dermatol. 2005 Sep;3(9):705–708.
  • Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, Lamba S, Lebwohl MG. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol. 2002 Oct;47(4):553–556.
  • Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000 Jul;43 (1 Pt 2):S6–11. Review.
  • Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002 Nov;138(11):1498–1502.
  • Stockfleth E, Sterry W, Carey-Yard M, Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol. 2007 Dec;157 Suppl 2:41–46.
  • Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004 Oct;51(4):547–555.
  • Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol. 2003 Oct;139(10):1325–1332.
  • Wehrli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous biology and disease. J Invest Dermatol. 2000 Aug;115(2):141–148. Review.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.